Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is common in the studied community, often linked to aging and hair care practices like braids, weaves, and chemical relaxers.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

Widened sweat ducts are a very specific sign of scarring hair loss.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Better hair loss models needed for research.

Systematic reviews on platelet-rich plasma therapy for hair loss have many quality issues.

Some African American women's central scalp hair loss is linked to genetics and past fungal scalp infections, with more research needed on other causes.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Loose Anagen Hair Syndrome is found in black-haired Indian children and is often missed, especially in boys.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

The new hair loss treatment combining nitric oxide and minoxidil in a special carrier is effective for hair regrowth.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Platelet-rich plasma therapy may help treat folliculitis decalvans but benefits might not last without ongoing treatment.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Ayurvedic treatment successfully regrew hair in a 7-year-old girl with alopecia areata.

Primary idiopathic pseudopelade of Brocq causes gradual, scarring hair loss with no effective treatment.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.